Sartorius Stedim Biotech(DE:56S1)
€222.80-4.20 (-1.85%)
DE:56S1
Sartorius Stedim Biotech ownership
€222.80
At close:-4.20 (-1.85%)
Sartorius Stedim Biotech (56S1) Ownership - Who Owns Sartorius Stedim Biotech?
12 Followers
Sartorius Stedim Biotech (56S1) Ownership Overview
- 3.20% Mutual Funds
- <0.01% Other Institutional Investors
- 3.72% ETFs
- 93.07% Public Companies and Individual Investors
The ownership structure of Sartorius Stedim Biotech (DE:56S1) stock is a mix of institutional, retail, and individual investors. Approximately 6.93% of the company’s stock is owned by Institutional Investors, and 93.07% is owned by Public Companies and Individual Investors.
The ownership structure of Sartorius Stedim Biotech (DE:56S1) stock is a mix of institutional, retail, and individual investors. Approximately 6.93% of the company’s stock is owned by Institutional Investors, and 93.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Dec 14, 2025 | Michael Grosse | €158,325,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 1,325,329 | Institution | 1.36% | 326,665,767 |
| Vanguard | 979,790 | Institution | 1.01% | 241,497,659 |
| Fidelity Select Portfolios | 613,000 | Institution | 0.63% | 151,091,627 |
| T. Rowe Price International Funds, Inc. | 517,997 | Institution | 0.53% | 127,675,383 |
| Vanguard Star Funds | 413,387 | Institution | 0.42% | 101,891,214 |
| Ubs | 326,620 | Institution | 0.34% | 80,504,971 |
| Vanguard Tax-managed Funds | 271,279 | Institution | 0.28% | 66,864,577 |
| Xtrackers | 243,484 | Institution | 0.25% | 60,013,693 |
| Amundi | 232,481 | Institution | 0.24% | 57,301,684 |
| Vanguard International Equity Index Funds | 155,198 | Institution | 0.16% | 38,253,048 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Select Portfolios | 613,000 | Institution | 0.63% | 151,091,627 |
| T. Rowe Price International Funds, Inc. | 517,997 | Institution | 0.53% | 127,675,383 |
| Vanguard Star Funds | 413,387 | Institution | 0.42% | 101,891,214 |
| Vanguard Tax-managed Funds | 271,279 | Institution | 0.28% | 66,864,577 |
| Vanguard International Equity Index Funds | 155,198 | Institution | 0.16% | 38,253,048 |
| Fidelity Advisor Series Vii | 125,000 | Institution | 0.13% | 30,809,875 |
| Fidelity Concord Street Trust | 115,533 | Institution | 0.12% | 28,476,458 |
| Fidelity Salem Street Trust | 102,124 | Institution | 0.10% | 25,171,421 |
| Bbh Trust | 97,723 | Institution | 0.10% | 24,086,667 |
| T. Rowe Price New Horizons Fund, Inc. | 97,493 | Institution | 0.10% | 24,029,977 |
FAQ
What percentage of Sartorius Stedim Biotech (DE:56S1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.93% of Sartorius Stedim Biotech (DE:56S1) stock is held by institutional investors: 3.20% by mutual funds, 3.72% by ETFs and <0.01% by other institutional investors.
What percentage of Sartorius Stedim Biotech (DE:56S1) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.07% of Sartorius Stedim Biotech (DE:56S1) stock is held by public companies and individual investors.
Who owns the most shares of Sartorius Stedim Biotech (DE:56S1)?
iShares owns the most shares of Sartorius Stedim Biotech (DE:56S1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
